These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24200103)

  • 21. Reasons for stimulant use among Latino gay men in San Francisco: a comparison between methamphetamine and cocaine users.
    Díaz RM; Heckert AL; Sánchez J
    J Urban Health; 2005 Mar; 82(1 Suppl 1):i71-8. PubMed ID: 15738318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analyses related to the development of DSM-5 criteria for substance use related disorders: 2. Proposed DSM-5 criteria for alcohol, cannabis, cocaine and heroin disorders in 663 substance abuse patients.
    Hasin DS; Fenton MC; Beseler C; Park JY; Wall MM
    Drug Alcohol Depend; 2012 Apr; 122(1-2):28-37. PubMed ID: 21963333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compatibility of current DSM-IV and proposed DSM-5 diagnostic criteria for cocaine use disorders.
    Proctor SL; Kopak AM; Hoffmann NG
    Addict Behav; 2012 Jun; 37(6):722-8. PubMed ID: 22386237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crosswalk between DSM-IV dependence and DSM-5 substance use disorders for opioids, cannabis, cocaine and alcohol.
    Compton WM; Dawson DA; Goldstein RB; Grant BF
    Drug Alcohol Depend; 2013 Sep; 132(1-2):387-90. PubMed ID: 23642316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dimensionality of hallucinogen and inhalant/solvent abuse and dependence criteria: implications for the Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition.
    Kerridge BT; Saha TD; Smith S; Chou PS; Pickering RP; Huang B; Ruan JW; Pulay AJ
    Addict Behav; 2011 Sep; 36(9):912-8. PubMed ID: 21621334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychometric evaluation of the DSM-IV criterion B mania symptoms in an Australian national sample.
    Carragher N; Weinstock LM; Strong D
    Psychol Med; 2013 Feb; 43(2):433-43. PubMed ID: 22578360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the invariance of the Stimulant Craving Questionnaire (STCQ) across cocaine and methamphetamine users.
    Northrup TF; Green C; Walker R; Greer TL; Trivedi MH
    Addict Behav; 2015 Mar; 42():144-7. PubMed ID: 25462663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is there a discrete negative symptom syndrome in people who use methamphetamine?
    Voce A; Burns R; Castle D; Calabria B; McKetin R
    Compr Psychiatry; 2019 Aug; 93():27-32. PubMed ID: 31301605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An item-response theory analysis of DSM-IV alcohol-use disorder criteria and "binge" drinking in undergraduates.
    Beseler CL; Taylor LA; Leeman RF
    J Stud Alcohol Drugs; 2010 May; 71(3):418-23. PubMed ID: 20409436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of a modified DSM-5 diagnosis of alcohol use disorder in a genetically informative population.
    Edwards AC; Gillespie NA; Aggen SH; Kendler KS
    Alcohol Clin Exp Res; 2013 Mar; 37(3):443-51. PubMed ID: 23347196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inter-observer reliability of DSM-5 substance use disorders.
    Denis CM; Gelernter J; Hart AB; Kranzler HR
    Drug Alcohol Depend; 2015 Aug; 153():229-35. PubMed ID: 26048641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized clinical trial on the effects of bupropion and buprenorphine on the reduction of methamphetamine craving.
    Ahmadi J; Sahraian A; Biuseh M
    Trials; 2019 Jul; 20(1):468. PubMed ID: 31362784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor and item-response analysis DSM-IV criteria for abuse of and dependence on cannabis, cocaine, hallucinogens, sedatives, stimulants and opioids.
    Gillespie NA; Neale MC; Prescott CA; Aggen SH; Kendler KS
    Addiction; 2007 Jun; 102(6):920-30. PubMed ID: 17523987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Item Response Theory Analysis to Assess Dimensionality of Substance Use Disorder Abuse and Dependence Symptoms.
    Kirisci L; Tarter RE; Reynolds M; Vanyukov MM
    Int J Pers Cent Med; 2016; 6(4):260-273. PubMed ID: 28944002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating brief screeners to discriminate between drug use disorders in a sample of treatment-seeking adults.
    Wu LT; Swartz MS; Pan JJ; Burchett B; Mannelli P; Yang C; Blazer DG
    Gen Hosp Psychiatry; 2013; 35(1):74-82. PubMed ID: 22819723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of cannabis use within a dimensional approach to cannabis use disorders.
    Compton WM; Saha TD; Conway KP; Grant BF
    Drug Alcohol Depend; 2009 Mar; 100(3):221-7. PubMed ID: 19062204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterogeneity of stimulant dependence: a national drug abuse treatment clinical trials network study.
    Wu LT; Blazer DG; Patkar AA; Stitzer ML; Wakim PG; Brooner RK
    Am J Addict; 2009; 18(3):206-18. PubMed ID: 19340639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A dimensional approach to understanding severity estimates and risk correlates of marijuana abuse and dependence in adults.
    Wu LT; Woody GE; Yang C; Pan JJ; Reeve BB; Blazer DG
    Int J Methods Psychiatr Res; 2012 Jun; 21(2):117-33. PubMed ID: 22351489
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Do DSM-5 substance use disorder criteria differ by user care settings? An item response theory analysis approach.
    Kervran C; Shmulewitz D; Serre F; Denis C; Roux P; Jauffret-Roustide M; Lalanne L; Hasin D; Auriacombe M
    Addict Behav; 2021 May; 116():106797. PubMed ID: 33450665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presence and persistence of psychotic symptoms in cocaine- versus methamphetamine-dependent participants.
    Mahoney JJ; Kalechstein AD; De La Garza R; Newton TF
    Am J Addict; 2008; 17(2):83-98. PubMed ID: 18393050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.